Wholesale of pharmaceutical and medical goods
ORIFARM NORWAY AS
Revenue 2024
NOK 142.0m
Operating profit
NOK −1.8bn
Equity
NOK 9.3bn
Incorporated
2020
Share capital
NOK 30,000
Roles
Daglig lederSverre Haugen
Regnskapsfører
Revisor
Styrets lederHans Carl Bøgh-Sørensen
StyremedlemMads Fink Eriksen
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| ORIFARM GROUP AS | 100.0% | 300.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.